Skip to main content
. 2021 Mar 7;13(3):348. doi: 10.3390/pharmaceutics13030348

Figure 3.

Figure 3

An overview of the pathophysiological events associated with the induction of atherosclerosis, therapeutic biomarkers for diagnosis and treatment of atherosclerosis and the advantages associated with nano-based theranostic tools for the management of CVDs.